Bringing Best Evidence to Clinicians – 2021 Annual Conference

Bringing Best Evidence to Clinicians – 2021 Annual Conference

The 2021 Annual Conference has taken place on October 16, 2021. Video recordings of selected portions of the program will be made available later.


This fall’s Bringing Best Evidence to Clinicians half-day virtual conference for healthcare providers looking to improve their practice. Keynote Speaker Julia Belluz, host of “Show Me the Evidence”, a journalist and senior health correspondent for Vox, will examine the science behind major headlines in health and medicine. Julia has covered topics including the anti-vaccine movement, shed light on major American health problems, and debunked popular pseudoscience media figures. She presented “Lessons from the trenches of evidence-based health journalism (How clinicians deal with patients that read medical journalism.)” Participants also received  practical, evidence-based prescribing advice from the Therapeutics Initiative faculty including Dr. Tom Perry, Dr. Aaron M Tejani, Dr. Josh Levin and Dr. Jamie Falk. Click here for more details…

KEY DETAILS

  • Date: Saturday, October 16, 2021
  • Time: 8:30-12:30 PDT [UTC -7; click here to convert to your time zone]
  • Venue: online
  • Mode of delivery: virtual conference
  • Accreditation: 3.75 Mainpro+/MOC Section 1
  • Intended audience: family physicians, nurse practitioners, nurses, pharmacists, allied health professionals, specialists, residents, and students; patients, caregivers, policy-makers are also welcome.
  • Fees: Cost varies, see full description below.

AGENDA

TIME PRESENTATION TITLE    SPEAKER
08:30 Welcome & Opening Remarks Dr. Aaron Tejani
08:40 Keynote Speaker Introduction Dr. Tom Perry
08:45 Keynote: Lessons from the trenches of evidence-based health journalism
(How clinicians deal with patients that read medical journalism)
Julia Belluz
09:45 A Deep Dive into SGLT2 inhibitors: What comes up to the surface for individual patients with diabetes?

  • Integrate evidence for the impact of SGLT2i on patient-relevant outcomes into clinical decision-making for patients with type 2 diabetes.
  • Apply our current understanding of SGLT2i adverse events to decisions for individual patients regarding if to use, how to use, and how to monitor this class of drugs.
  • Evaluate efficacy, harm, cost, and burden of SGLT2i use in the context of other drug and non-drug modalities used in the management of diabetes.
Dr. Jamie Falk
10:20 Break
10:35 Exercise Prescriptions: evidence and clinical applications

  • Become familiar with some of the evidence for prescribing exercise in the primary care setting.
  • Become familiar with the key components of an effective exercise prescription.
  • Become familiar with some of the most common barriers faced when trying to get patients more physically active, as well as some tips for overcoming them.
Dr. Josh Levin
11:10 How well do you know the drugs you prescribe?
(Listening and observing thoughtfully can protect your patients from pointless adverse effects)

  • After viewing and thinking about patient videos presented in this session, learners will be better able to ask about common adverse drug effects, and to observe patients to detect them.
  • Learners will better appreciate that we often fail to understand important adverse drug effects that are right under our eyes or ears.
Dr. Tom Perry
11:40 Common Prescribing Cascades & Is there a dose response for efficacy and harm?
(Assessing the evidence for commonly prescribed medicines)
Dr. Aaron Tejani
12:15 Key Messages & Closing Remarks Dr. Aaron Tejani
12:30 Conference Ends

COST

Delegate $125.00
Resident $55.00
Student $30.00

All fees are in Canadian dollars. 5% GST applies to all fees.

Registration included: Access to the live virtual event, all available resources & materials, and access to the post-event recordings.

“Fabulous event – timely topics, dynamic presentations, good question periods, agenda kept flowing on time.”
No Comments

Post A Comment